Abstract:Accumulating evidence has revealed that an elevated expression level of Aurora-B is associated with metastasis in various type l of malignant tumor. However, it is currently unclear whether this molecule is involved in non-small lung cancer (NSCLC) metastasis, and the molecular mechanisms associated with Aurora-B and metastasis remain unknown. In the present study, in order to investigate whether Aurora-B is involved in the development and metastasis of NSCLC, the Aurora-B protein expression in NSCLC tissues was detected by immunohistochemistry and its association with metastasis was analyzed. The results. revealed that the expression levels of the Aurora-B protein in tissues obtained from NSCLC patients with lymph node metastasis were significantly higher than those without metastatic disease. Furthermore, the effect of Aurora-B inhibition on A549 cell migration and invasion, as well as the activity of the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway was evaluated. Aurora-B was inhibited in the A549 cells using short hairpin RNA, and the cell migration and invasion rates were investigated using wound healing and Transwell invasion assays. In addition, the expression of the main proteins in the PI3K/Akt/nuclear factor-kappa B (NF-kappa B) signaling pathway, and matrix metalloproteinase (MMP)-2 and -9 were measured by western blot analysis. The results demonstrated that cell migration and invasion were decreased as a result of silencing Aurora-B. Furthermore, the activity of the PI3K/Akt/NF-kappa B signaling pathway and the expression of MMP-2 and -9 protein were suppressed by silencing Aurora-B. The results of the present study indicate that the knockdown of Aurora-B suppresses A549 cell invasion and migration via the inhibition of the PI3K/Akt signaling pathway in vitro and thus, targeting Aurora-B may present a potential treatment strategy for NSCLC.

Effects of Stable Knockdown of Aurora Kinase A on Proliferation, Migration, Chromosomal Instability, and Expression of Focal Adhesion Kinase and Matrix Metalloproteinase-2 in HEp-2 Cells

[Suppression of Aurora-A by RNA Interference Inhibits Laryngeal Cancer Hep-2 Cell Growth].

Activation of the FAK/PI3K Pathway is Crucial for AURKA-induced Epithelial-Mesenchymal Transition in Laryngeal Cancer

Aurora Kinase A Induces Chemotherapy Resistance Through Revival of Dormant Cells in Laryngeal Squamous Cell Carcinoma

Aurora Kinase A Revives Dormant Laryngeal Squamous Cell Carcinoma Cells Via FAK/PI3K/Akt Pathway Activation

AURKA Promotes Cell Migration and Invasion of Head and Neck Squamous Cell Carcinoma Through Regulation of the AURKA/Akt/FAK Signaling Pathway.

Overexpression of Aurora-A promotes laryngeal cancer progression by enhancing invasive ability and chromosomal instability

Aurora-A, A Negative Prognostic Marker, Increases Migration and Decreases Radiosensitivity in Cancer Cells

RNA Interference-Mediated Knockdown of Aurora-B Alters the Metastatic Behavior of A549 Cells Via Modulation of the Phosphoinositide 3-Kinase/akt Signaling Pathway

Knockdown of AURKA Sensitizes the Efficacy of Radiation in Human Colorectal Cancer.

Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints

AURKA knockdown inhibits esophageal squamous cell carcinoma progression through ferroptosis

M1611 Epigenetic Characterization of a Novel Tumor Suppressor Gene, RNF180, in Gastric Cancer and Its Application in Noninvasive Cancer Detection

Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to Its Aggressive Behavior

RNA interference (RNAi) mediated stable knockdown of protein casein kinase 2-alpha (CK2α) inhibits migration and invasion and enhances cisplatin-induced apoptosis in HEp-2 laryngeal carcinoma cells.

Aurora A Is Essential for Early Embryonic Development and Tumor Suppression

Therapeutic Rationale to Target Highly Expressed Aurora Kinase A Conferring Poor Prognosis in Cholangiocarcinoma

AURKA Promotes Renal Cell Carcinoma Progression Via Regulation of CCNB1 Transcription

Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration

Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers

Stable knockdown of Aurora-A by vector-based RNA interference in human esophageal squamous cell carcinoma cell line inhibits tumor cell proliferation, invasion and enhances apoptosis.